p53 as a regulator of cell differentiation

• US 6,479,285 B1
• Filed: 07/01/1998
• Issued: 11/12/2002
• Est. Priority Date: 07/02/1997
• Status: Expired due to Fees

• Current Assignee: Board of Regents of the University of Texas System (University of Texas System)
• Original Assignee: Board of Regents of the University of Texas System (University of Texas System)
• Inventors: Wallingford, John B., Vize, Peter D.
• Primary Examiner(s): Priebe, Scott D.
• Assistant Examiner(s): Kaushal, Sumesh
• Application Number:
  US09/108,843
• Time in Patent Office: 1,595 Days
• Field of Search: 435/6, 435/455, 435/459, 435/461, 435/320.1, 435/325, 435/375, 435/377, 424/9.1, 424/9.2, 424/93.1, 424/93.2, 800/21, 800/23, 800/25, 536/23.1, 536/23.5
• US Class Current: 435/377
• CPC Class Codes: G01N 2333/47 Assays involving proteins of known structure or function as defined in the subgroups
• CPC Class Codes: G01N 2333/4703 Regulators; Modulating activity
• CPC Class Codes: G01N 33/5011 for testing antineoplastic activity
• CPC Class Codes: G01N 33/68 involving proteins, peptides or amino acids involving lipoproteins G01N33/92

Abstract

The present invention involves the role of p53 in the differentiation of embryonic tissues. More particularly, the present invention provides methods of the blocking of p53 function in embryonic tissues, and the use of these tissues as screening tools for substances that are capable of overcoming the p53-related block in differentation, both in vitro and in vivo. The similarities between undifferentiated embryonic cells and tumor cells is evident, and thus these assays serve as a model for possible cancer therapeutics. In addition, methods for identifying additional cellular components that interact p53 or p53-related pathways are provided.

Claims

1. A method of screening for agents that inhibit a block of p53-related embryonic cell differentiation comprising the steps of:

(i) providing an isolated, undifferentiated embryonic cell;

(ii) blocking the function of p53 in said cell such that said cell fails to differentiate;

(iii) contacting said cell with a candidate agent; and

(iv) comparing the differentiation of said contacted cell after said contacting with the differentiation of said cell in the absence of said candidate agent;

whereby an increase in differentiation indicates that said candidate agent is an inhibitor of the block of p53-related differentiation.

2. The method of claim 1, further comprising the step of comparing the differentiation of said cell after said contacting with the differentiation of said undifferentiated embryonic cell.

3. The method of claim 1, wherein said cell is a mammalian cell.

4. The method of claim 3, wherein said cell is a mouse cell.

5. The method of claim 3, wherein said cell is a human cell.

6. The method of claim 1, wherein said blocking is achieved by introducing into said cell a nucleic acid encoding a dominant negative mutant of p53.

7. The method of claim 6, wherein said introducing is achieved via electroporation, microinjection, particle bombardment, liposome transfer or viral infection.

8. The method of claim 6, wherein said nucleic acid is a DNA.

9. The method of claim 6, wherein said nucleic acid is an RNA.

10. The method of claim 1, wherein said candidate agent is polypeptide.

11. The method of claim 1, wherein said candidate agent is produced by a neighboring cell.

12. The method of claim 11, wherein said neighboring cell is a second undifferentiated embryonic cell into which said candidate.agent has been introduced.

13. The method of claim 1, wherein differentiation is determined by culture of said undifferentiated embryonic cell in vitro under conditions where said cell differentiates.